prodchem
Aug 24, 2026
Berkshire Hathaway's expansion of its chemical portfolio through Lubrizol and OxyChem has created a chemical manufacturing platform with substantial scale inside one of the world's largest industrial conglomerates. In Q2 2026, Lubrizol generated $1.8 billion in revenue, while OxyChem generated $1.4 billion, putting their combined quarterly revenue at roughly $3.2 billion.
For chemical traders, procurement managers, manufacturers and industry analysts, the combination provides an important benchmark for evaluating the scale advantages of diversified chemical platforms compared with standalone producers.
The acquisition of OxyChem marked an important expansion of Berkshire's position in the chemical industry.
Berkshire completed the acquisition of OxyChem from Occidental Petroleum on January 2, 2026, bringing the business into its industrial products group alongside Lubrizol.
The move effectively added a large basic-chemicals operation to Berkshire's existing specialty-chemical exposure through Lubrizol.
That creates a portfolio spanning different parts of the chemical value chain.
Lubrizol is Berkshire's established specialty-chemicals platform.
Its products serve markets including:
Automotive
Industrial applications
Lubricants
Coatings
Performance materials
Specialty formulations
In Q2 2026, Lubrizol generated $1.8 billion in revenue, up 11.1% year over year. Pre-tax earnings increased 23.4%.
The improvement was attributed primarily to higher volumes and selling prices, although higher raw-material and manufacturing costs remained a pressure.
OxyChem brings a different type of chemical exposure.
The business produces basic chemicals and became part of Berkshire's consolidated results beginning January 2026.
In Q2, OxyChem generated:
$1.4 billion revenue
$149 million pre-tax earnings
Its first-half results were affected by acquisition accounting, depreciation and transition costs associated with the transaction.
This makes OxyChem a substantial contributor despite being only partway through its first year under Berkshire ownership.
Combining Q2 revenue from the two businesses produces approximately $3.2 billion in quarterly chemical sales.
That is a meaningful scale benchmark.
It places Berkshire's two chemical operations in a different category from many smaller standalone specialty-chemical companies.
More importantly, the businesses are complementary rather than identical.
Lubrizol = specialty chemicals
OxyChem = basic chemicals
This diversification can help Berkshire participate across multiple chemical market cycles.
The chemical businesses sit within Berkshire's much larger industrial products group.
The group generated $12.2 billion of revenue in Q2 2026, up 27.3% year over year, with pre-tax earnings rising 41.0%.
The increase was primarily attributable to acquisitions and growth across several existing businesses.
This matters because Lubrizol and OxyChem are not operating as isolated chemical assets.
They benefit from being part of an enormous diversified industrial organization.
Large chemical platforms can potentially benefit from greater purchasing power.
For chemical producers, procurement represents a major cost category across:
Feedstocks
Energy
Packaging
Logistics
Equipment
Maintenance
Industrial services
A larger parent company may have greater ability to negotiate across these categories.
Berkshire's size can therefore provide strategic advantages that smaller standalone chemical producers may not possess.
One of the most important advantages of combining Lubrizol and OxyChem is diversification.
Different chemical markets experience different cycles.
Basic chemicals can be heavily influenced by:
Feedstock costs
Industrial production
Construction
Commodity pricing
Global capacity
Specialty chemicals can instead depend more heavily on:
Product qualification
Formulation demand
Automotive production
Industrial applications
Technology trends
Owning both gives Berkshire exposure to multiple demand drivers.
The OxyChem acquisition also gives Berkshire greater exposure to large-volume chemical markets.
This can increase sensitivity to commodity cycles, but it also provides access to established industrial demand.
For chemical traders, OxyChem's scale can make Berkshire an increasingly important participant in North American chemical supply.
Lubrizol's specialty positioning provides a different economic profile.
Specialty chemical producers can often differentiate products through:
Technical performance
Formulation
Customer qualification
Application expertise
Product consistency
That can create stronger customer relationships than purely commodity-oriented chemical businesses.
Berkshire therefore now has exposure to both scale-driven commodity chemistry and differentiated specialty materials.
The most useful comparison is not simply revenue.
Standalone chemical companies must often manage their own:
Financing
Capital allocation
Procurement
Technology investment
Manufacturing footprint
Working capital
Berkshire's chemical businesses operate within a much larger financial ecosystem.
That can potentially give them greater flexibility during periods of market volatility.
The comparison therefore involves corporate financial strength as well as chemical production scale.
Chemical procurement teams should pay attention to this development because Berkshire's ownership structure could influence supplier relationships.
A large industrial buyer may have greater negotiating leverage across its operations.
Potential advantages include:
Larger purchasing volumes
Longer-term supplier agreements
Greater inventory flexibility
Better financing capacity
Broader logistics networks
These factors can become particularly valuable when raw-material or energy costs rise.
Lubrizol's Q2 results illustrate the challenge.
Berkshire reported that Lubrizol's higher selling prices were necessary because of significant increases in raw-material, energy and supply-chain costs beginning late in Q1 and continuing through Q2.
The ability to pass some of those costs through to customers is an important indicator of pricing power.
For chemical buyers, however, it also means Berkshire's expanded chemical platform may not necessarily translate into lower product prices.
Scale and pricing power can work in both directions.
Berkshire is known for maintaining significant financial resources and taking a long-term approach to its operating businesses.
That could give OxyChem access to capital for:
Plant modernization
Reliability improvements
Capacity investment
Environmental compliance
Energy efficiency
Technology upgrades
The long-term ownership structure may therefore influence how the business approaches capital spending compared with a standalone chemical company.
Basic chemical manufacturing carries significant environmental and regulatory obligations.
OxyChem's operations therefore require continued investment in:
Emissions controls
Water management
Waste treatment
Process safety
Regulatory compliance
Plant modernization
A financially strong parent can potentially provide greater capacity to fund these requirements over long investment horizons.
For traders, Berkshire's expanded chemical footprint creates another large participant to monitor.
The most important areas to watch include:
OxyChem production rates
Chlor-alkali market conditions
Lubrizol pricing
Raw-material costs
North American chemical demand
Export flows
Plant utilization
Berkshire's future chemical acquisitions
The platform could become increasingly important in North American chemical supply chains.
The OxyChem acquisition also raises a broader industry question.
If Berkshire views chemical manufacturing as an attractive long-term industrial asset, additional acquisitions could become possible.
That could include businesses in:
Specialty chemicals
Performance materials
Industrial chemicals
Chemical intermediates
Advanced materials
Such moves would further increase the scale of Berkshire's chemical platform.
Berkshire's model differs fundamentally from a conventional standalone chemical producer.
Its chemical businesses are part of a diversified conglomerate containing companies across numerous industrial sectors.
This means chemical performance does not determine Berkshire's overall financial health.
For the chemical businesses themselves, however, that structure can provide access to a parent company with considerable financial resources and a long-term ownership orientation.
The Q2 numbers provide a straightforward benchmark:
Lubrizol: ~$1.8 billion
OxyChem: ~$1.4 billion
Combined: ~$3.2 billion quarterly chemical revenue
Those figures make the Berkshire chemical platform substantial even before considering the broader industrial businesses surrounding it.
Berkshire's ownership of Lubrizol and OxyChem has created one of the more unusual chemical platforms in the industry: a combination of specialty-chemical expertise and large-scale basic-chemical manufacturing under a financially powerful parent.
The platform's approximately $3.2 billion of combined Q2 revenue provides a useful scale benchmark against standalone chemical companies.
The more important question through 2026 and beyond will be whether Berkshire can use that scale to improve operating efficiency, strengthen capital investment and expand its chemical footprint.
For procurement teams and chemical traders, the development is worth watching because Berkshire is no longer simply an investor with a specialty-chemical asset. It is becoming a major multi-segment chemical producer in its own right.
Berkshire now owns both Lubrizol and OxyChem, giving it exposure to specialty and basic chemicals.
Lubrizol generated approximately $1.8 billion in Q2 2026 revenue.
OxyChem generated approximately $1.4 billion in Q2 revenue.
Their combined quarterly revenue was approximately $3.2 billion.
Berkshire's broader industrial products group generated $12.2 billion in Q2 revenue.
OxyChem adds significant basic-chemical exposure to Berkshire's existing specialty-chemical portfolio.
Lubrizol provides differentiated specialty-chemical exposure across industrial and consumer applications.
Berkshire's financial scale may provide advantages in capital allocation and supplier negotiations.
Rising raw-material and energy costs remain important challenges for the chemical businesses.
The combined platform is an increasingly important benchmark for chemical-industry scale and consolidation.
Featured Product
Found this useful?
Continue Reading
Chemours has pushed through multiple titanium dioxide price increases in 2026 even as it commits to major environmental compliance spending following its EPA settlement. Buyers should understand which cost pressures are actually driving the pricing.
Orion's second quarter results show premium carbon black demand holding strong across Western markets while Asian conditions stay soft. The divergence carries real implications for how buyers plan sourcing and pricing across regions.
